JADE SCORE PTA Scoring Balloon Dilatation Catheter
OrbusNeich Medical (Shenzhen) Co., Ltd. · Decision date Sep 16, 2026
What did the FDA decide?
FDA's 510(k) database records K261778 as a traditional premarket notification from OrbusNeich Medical (Shenzhen) Co., Ltd. for the JADE SCORE PTA Scoring Balloon Dilatation Catheter, classified under 21 CFR 870.1250 (Catheter, Percutaneous, Cutting/Scoring), product code PNO, in the Cardiovascular specialty. The decision is Substantially Equivalent (SESE), dated September 16, 2026, which is a clearance to market rather than a PMA approval. The database lists a received date of May 29, 2026, while the clearance letter states the submission was dated and received August 13, 2026; the source does not reconcile the discrepancy.
The 510(k) summary describes two versions: a 14 Rx rapid-exchange configuration for 0.014-inch guidewires and an 18 OTW over-the-wire configuration for 0.018-inch guidewires. It names the UltraScore Focused Force PTA Balloon (K163420) as predicate and Scoreflex (K182713) and JADE PLUS (K241025) as reference devices, citing the same indications, hydrophilic coating, scoring element and EO sterilization, with differences limited to specific materials and component dimensions. The summary states in vitro tests met acceptance criteria; no clinical outcome data are presented, and the enclosure's age-group selections are not legible in the provided text.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Cardiovascular
- Decision date
- Sep 16, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K261778
- Regulatory pathway
- 510(k) premarket notification
- Product code
- PNO
- Decision code
- SESE
- Decision date
- Sep 16, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Catheter, Percutaneous, Cutting/Scoring.
- Product code
- PNO
- FDA device class
- 2
FDA decision timeline
K261778 received
Application receipt date recorded by FDA.
K261778 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code PNO
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Zylox Medtech Co., Ltd. | 510(k) clearance | Oct 22, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
OrbusNeich Medical (Shenzhen) Co., Ltd.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Shenzhen
Sources and methodology
- Original FDA record: K261778
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records